Mematen 10 Tablet contains Memantine 10mg, an NMDA receptor antagonist widely prescribed for moderate to severe Alzheimer’s disease. It helps regulate glutamate activity in the brain, improving cognitive function and reducing symptoms like memory loss, confusion, and behavioral disturbances.
Belonging to the neurology and CNS segment, Mematen 10 is recommended for patients experiencing progressive cognitive decline. Its efficacy in slowing symptom progression makes it a critical therapeutic option for long-term Alzheimer’s management.
The tablet ensures consistent brain function support, enhancing quality of life and daily functionality for patients. Hospitals, neurology clinics, and geriatric care centers frequently prescribe Mematen 10 due to its proven clinical benefits.
For PCD pharma franchise partners, wholesalers, exporters, and third-party manufacturers, Mematen 10 Tablet provides a profitable B2B opportunity in the neurology segment, with stable demand and strong market growth potential across India.